CYCLOSPORIN A (SANDIMMUN NEORAL) IN THERAPY FOR PSORIASIS AND PSORIATIC ARTHRITIS
The involvement of immune mechanisms in the pathogenesis of psoriatic arthritis (PA) is noted to give grounds to use immunoactive compounds (disease- modifying agents - basic anti-inflammatory drugs -BAIDs), such as cyclosporin A (CsA), in this disease. The data available in the literature permit a...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
IMA-PRESS LLC
2010-09-01
|
| Serie: | Современная ревматология |
| Soggetti: | |
| Accesso online: | https://mrj.ima-press.net/mrj/article/view/307 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|